CSF1R and glioblastoma: Previous efforts have centered on developing CSF1R inhibitors to deplete TAMs in GBM, but the results showed that CSF1R inhibition only induces a transient antitumor effect caused by the compensatory changes in macrophages after the treatment in brain tumors (45, 46).